Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AAOS recommends against vertebroplasty

This article was originally published in The Gray Sheet

Executive Summary

American Academy of Orthopaedic Surgeons is recommending against use of vertebroplasty to treat symptomatic osteoporotic spinal compression fractures, according to a Sept. 24 clinical practice 1guideline. Stephen Esses, M.D., Southwest Orthopedic Group, who chaired the volunteer physician workgroup that developed the guideline, said the group reviewed literature over several years and concluded "vertebroplasty does not provide the types of benefits that it was previously thought to provide." Vertebroplasty is the percutaneous injection of polymethylmethacrylate (PMMA) into a fractured vertebral body to alleviate pain and stabilize the spine. The recommendation against the procedure is largely based on two randomized studies published in the New England Journal of Medicine finding that vertebroplasty provided no lasting benefit over sham procedures (2"The Gray Sheet" Aug. 10, 2009)

Related Content

Topics

UsernamePublicRestriction

Register

MT029442

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel